Surgery, Neurology, Orthopedics. This company has developed a tissue resection system indicated for the removal of tumors and tissue from highly delicate areas including the head and the spinal cord. The company’s tissue dissection technology is endoscope-based and allows clinicians to perform minimally invasive procedures as well as traditional brain and spinal surgeries, such as open craniotomies and endonasal procedures, with increased efficiency and improved patient outcome. The company’s endoscopic technology enables a reduction in procedure times, blood loss and recovery time thereby minimizing the occurrence of collateral tissue damage. The company announced that it had $10 million in investment funding in July 2009. Founded: 2007.